Following these observations, we correlated the average integrated intensity (normalized to ROI area) of each OATP isoform with cell-type specific markers in GBM and non-tumor cases to determine if OATP expression was preferentially driven by a specific cell population. The gene discussed is SLCO1A2; the disease is glioblastoma.